Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

PURPOSE: On the basis of the ACCORD trial, FOLFIRINOX is effective in metastatic pancreatic adenocarcinoma (PDAC), making it a rational choice for locally advanced PDAC (LA). Aims of this study are to evaluate the accuracy of imaging in determining the resectability of PDAC and to determine the surg...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Surg
Huvudupphovsmän: Ferrone, Cristina R., Marchegiani, Giovanni, Hong, Theodore S., Ryan, David P., Deshpande, Vikram, McDonnell, Erin I., Sabbatino, Francesco, Santos, Daniela Dias, Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Faris, Jason E., Goyal, Lipika, Kwak, Eunice L., Murphy, Janet E., Ting, David T., Wo, Jennifer Y., Zhu, Andrew X., Warshaw, Andrew L., Lillemoe, Keith D., Castillo, Carlos Fernández-del
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349683/
https://ncbi.nlm.nih.gov/pubmed/25599322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000000867
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk